AK Medical Statements
17
Data from AK Medical`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency :
CNY - Chinese yuan
Last reporting period :
30 Jun, 2024
New report :
—
Reporting period :
Semi-annual
Earnings release date:
—
Expected release date:
28 Aug, 2024
AK Medical Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
657.1
47.6 %
100
258.62
39.4
398.48
46 %
60.6
63.575
9.7
185.31
28.2
245.99
19.9 %
37.4
152.49
125 %
23.2
10.03
1.5
—
0
162.52
122.2 %
24.7
23.271
3.5
139.25
181.1 %
21.2
0.125
1 117.88
445.18
-31.4 %
100
172.25
38.7
272.92
-32 %
61.3
70.801
15.9
159.67
35.9
205.15
-20.4 %
46.1
67.773
-52.8 %
15.2
5.356
1.2
—
0
73.129
-53.7 %
16.4
23.599
5.3
49.53
-62.6 %
11.1
0.044
1 118.41
648.69
24.5 %
247.12
401.56
34.8 %
66.325
192.58
257.86
32.6 %
143.71
38.9 %
14.278
—
157.99
73.9 %
25.414
132.57
68.4 %
0.118
1 119.97
520.84
-2 %
100
222.94
42.8
297.9
-12 %
57.2
56.466
10.8
144.17
27.7
194.4
-4.6 %
37.3
103.5
-23.2 %
19.9
5.696
1.1
—
0
90.836
-39.2 %
17.4
12.097
2.3
78.739
-37.5 %
15.1
0.07
1 119.24
531.21
69.3 %
100
192.68
36.3
338.54
77.4 %
63.7
54.399
10.2
154.25
29
203.69
-7.6 %
38.3
134.84
557.4 %
25.4
14.611
2.8
—
0
149.45
748.3 %
28.1
23.421
4.4
126.03
768.1 %
23.7
0.113
1 115.67
313.81
-29.9 %
100
122.95
39.2
190.86
-38.1 %
60.8
61.332
19.5
162.91
51.9
220.34
22.8 %
70.2
-29.483
-122.9 %
-9.4
6.43
2
—
0
-23.053
-117.5 %
-7.3
-4.189
-1.3
-18.864
-116.9 %
-6.01
-0.017
1 111.03
447.63
-19.5 %
100
139.3
31.1
308.33
-18.5 %
68.9
51.737
11.6
129.76
29
179.41
-6.9 %
40.1
128.92
-30.5 %
28.8
2.693
0.6
—
0
131.61
-26.8 %
29.4
20.129
4.5
111.48
-26.2 %
24.9
0.1
1 115.73
556.41
16.2 %
100
178.2
32
378.21
12.5 %
68
61.074
11
136.11
24.5
192.79
33.9 %
34.6
185.42
-3.6 %
33.3
3.166
0.6
—
0
179.74
-8.7 %
32.3
28.6
5.1
151.14
-7.2 %
27.2
0.134
1 124.95
478.98
-2 %
100
142.66
29.8
336.32
-0.7 %
70.2
43.9
9.2
101.01
21.1
143.97
-18.3 %
30.1
192.36
18.4 %
40.2
4.515
0.9
—
0
196.87
19.3 %
41.1
34
7.1
162.87
18.5 %
34
0.15
1 089.38
488.92
11.7 %
100
150.25
30.7
338.67
11.2 %
69.3
45.393
9.3
135.57
27.7
176.17
16.2 %
36
162.51
6.2 %
33.2
2.446
0.5
—
0
164.95
5.4 %
33.7
27.516
5.6
137.44
6.1 %
28.1
0.129
1 067.35
437.78
34.5 %
100
133.2
30.4
304.58
39.7 %
69.6
35.134
8
131.97
30.1
151.56
14.2 %
34.6
153.01
79.3 %
35
3.435
0.8
—
0
156.45
80.8 %
35.7
26.894
6.1
129.56
76.2 %
29.6
0.123
1 049.31
325.56
18.4 %
100
107.48
33
218.07
14.3 %
67
26.03
8
111.18
34.1
132.71
26.5 %
40.8
85.36
-0.6 %
26.2
1.187
0.4
—
0
86.547
-1.6 %
26.6
13.003
4
73.544
3 %
22.6
0.07
1 053.81
275.01
30.8 %
100
84.198
30.6
190.81
25.5 %
69.4
19.565
7.1
85.826
31.2
104.94
23.6 %
38.2
85.867
27.8 %
31.2
2.086
0.8
—
0
87.953
30.9 %
32
16.561
6
71.392
29 %
26
0.069
1 041.57
210.18
29.3 %
58.096
152.09
36.2 %
17.034
68.683
84.891
57.2 %
67.196
16.5 %
0.018
—
67.214
15.5 %
11.888
55.326
10.5 %
0.072
767.86
162.52
4.6 %
50.814
111.7
4 %
17.929
37.936
54.011
4.3 %
57.692
3.6 %
0.478
—
58.17
3.3 %
8.12
50.05
13.5 %
0.067
750
155.4
34.8 %
48
107.4
34.4 %
12.1
40.1
51.8
23 %
55.7
47.7 %
0.7
-0.4
56.3
45.5 %
12.2
44.1
32.8 %
0.06
750
115.3
—
35.5
79.9
—
8.3
34.3
42.1
—
37.7
—
1
-0.4
38.7
—
5.5
33.2
—
0.04
750